Emergent BioSolutions Inc.: Form 8-K, filed Oct 5, 2018
Filed with the SEC on Oct 5, 2018 and accepted by EDGAR at Oct 4, 2018, 19:22 ET.
Items reported
- Item 2.01 Completion of an acquisition or disposition
- Item 2.03 New direct financial obligation
- Item 7.01 Regulation FD disclosure
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001104659-18-060601. Last ingested by Listed: Nov 4, 2026, 16:51 ET. Listed shows no prices and gives no investment advice.